首页 | 本学科首页   官方微博 | 高级检索  
     

三种不同化放疗方法对宫颈癌患者术前辅助治疗效果对比研究
引用本文:赵红利,杨琴,龚钿,汪小舟,黄春梅,张仕田,李嵘. 三种不同化放疗方法对宫颈癌患者术前辅助治疗效果对比研究[J]. 中国临床保健杂志, 2021, 24(1): 125-128
作者姓名:赵红利  杨琴  龚钿  汪小舟  黄春梅  张仕田  李嵘
作者单位:四川大学华西医院眉山医院/眉山市人民医院妇科 妇产科,眉山620010;四川大学华西医院眉山医院/眉山市人民医院妇科 放射科,眉山620010;四川大学华西医院眉山医院/眉山市人民医院妇科 肿瘤科,眉山620010
基金项目:四川省眉山市科技局基金项目(20180042)。
摘    要:目的 观察子宫动脉灌注栓塞化疗、全身静脉化疗和体外放疗在宫颈癌Ⅰb2期到Ⅱb期患者术前辅助治疗中的疗效.方法 选择2017年1月至2020年1月在眉山市人民医院妇科收治的原发性宫颈癌患者220例,在行手术治疗前,依据治疗方式分为子宫动脉灌注栓塞化疗组72例,全身静脉化疗组75例和体外放疗组73例,术后1个月观察3组患者...

关 键 词:宫颈肿瘤  化学疗法  辅助  放射疗法  治疗结果

A comparative study of the effect of three different chemoradiotherapy on the preoperative adjuvant treatment of cervical cancer patients
Zhao Hongli,Yang Qin,Gong Dian,Wang Xiaozhou,Huang Chunmei,Zhang Shitian,Li Rong. A comparative study of the effect of three different chemoradiotherapy on the preoperative adjuvant treatment of cervical cancer patients[J]. Chinese Journal of Clinical Healthcare, 2021, 24(1): 125-128
Authors:Zhao Hongli  Yang Qin  Gong Dian  Wang Xiaozhou  Huang Chunmei  Zhang Shitian  Li Rong
Affiliation:(Department of Obstetrician of Gynecologist,Meishan People′s Hospital of Sichuan Province,Meishan 620010,China;不详)
Abstract:Objective To observe the efficacy of uterine artery perfusion embolization chemotherapy,systemic intravenous chemotherapy,and extracorporeal radiotherapy in preoperative adjuvant therapy in patients with cervical cancer stagesⅠb2 toⅡb.Methods A total of 220 patients with primary cervical cancer admitted to the gynecology department of Meishan People′s Hospital from January 2017 to January 2020 were selected and divided into 72 cases of uterine artery perfusion embolization chemotherapy group,75 cases of systemic intravenous chemotherapy group and 73 cases of extracorporeal radiotherapy group according to their treatment before surgery,and the recent clinical symptom relief,mass regression and the occurrence of gastrointestinal adverse reactions in the three groups were observed one month after surgery.Results After 1 month of treatment,(1)all 3 groups of patients had varying degrees of clinical remission,and the uterine artery perfusion embolization chemotherapy group had total remission rate 83.33%,which was better than 68.00%in the systemic intravenous chemotherapy group and 68.00%in the extracorporeal radiotherapy group 64.38%;(2)patients in the uterine artery perfusion embolization chemotherapy group had significantly better mass regression than the whole body.The overall effective rate of uterine artery perfusion embolization chemotherapy was 87.50%in the intravenous chemotherapy and extracorporeal radiotherapy groups,which significantly higher than 72.00%in the systemic intravenous chemotherapy group and 68.49%in the extracorporeal radiotherapy group.(3)the nonresponse rate in the uterine artery perfusion embolization chemotherapy group 43.06%was significantly higher than 20.55%in the extracorporeal radiotherapy group,the above difference,the comparisons were statistically significant(P<0.05).Conclusion Uterine artery perfusion embolization chemotherapy combined with surgery can effectively control the development of cervical cancer patients from stageⅠb2 to stageⅡb,and can improve the short-term clinical symptoms remission rate,the efficacy is superior to systemic intravenous chemotherapy and external radiotherapy with low incidence of gastrointestinal adverse reactions.
Keywords:Uterine cervical neoplasms  chemotherapy,Adjuvant  Radiotherapy,adjuvant  Treatment outcome
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号